Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evocalcet - Mitsubishi Tanabe Pharma Corporation

Next Previous
Drug Profile

Evocalcet - Mitsubishi Tanabe Pharma Corporation

Alternative Names: Evocalcet; KHK 4580; KHK-7580; MT-4580; ORKEDIA

Latest Information Update: 23 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mitsubishi Tanabe Pharma Corporation
  • Developer Kyowa Kirin
  • Class Antihypercalcaemics; Antithyroids; Naphthalenes; Pyrrolidines; Small molecules
  • Mechanism of Action Calcium-sensing receptor agonists; Parathyroid hormone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hypercalcaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Secondary hyperparathyroidism
  • Registered Hypercalcaemia

Most Recent Events

  • 30 Jun 2024 Registered for Secondary hyperparathyroidism in China (PO) before June 2024 (Kyowa Kirin pipeline, August 2024)
  • 29 Feb 2024 Registered for Secondary hyperparathyroidism in Taiwan (PO)
  • 30 Nov 2023 Registered for Secondary hyperparathyroidism in South Korea (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top